Hemodynamics, fluids & transfusion

Direct assessment of microcirculation in shock: a randomized-controlled multicenter study

Intensive Care MedPublished Randomised controlled trial

An erratum to this article was published (Intensive Care Med, Oct 2023 ↗)

Authors' conclusion

Integrating sublingual microcirculatory perfusion variables in the therapy plan resulted in treatment changes that do not improve survival at all.

Study context

Population
Intensive care unit (ICU) patients with shock (arterial lactate >2 mmol/L, requiring vasopressors despite adequate fluid resuscitation), any cause
Participants
141 patients
Comparison
Intervention vs Routine care
  • Interventionn = 69
  • Routine caren = 72reference
Primary endpoint
30-day mortality
Follow-up
30 days
Methodological detailsprospective, multicentre, Sublingual sidestream-dark field (SDF) measurements at ICU admission (± 4 h) and 24 (± 4) hours later, performed blinded to the treatment team
  • Prospective
  • Multicentre
  • Sublingual SDF measurements at ICU admission (± 4 h) and 24 (± 4) hours later, performed blinded to the treatment team

Primary result

As reported in the abstract

  • 30-day mortality did not differ

Secondary outcomes

Adjustment in vasoactive drugs or fluids within the next hour

P = 0.009

Microcirculatory values · 24 h after admission

Did not differ between groups

Safety

Serious adverse events

No serious adverse events (SAEs) occurred

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Direct assessment of microcirculation in shock: a randomized-controlled multicenter study. Intensive Care Med. Published 6 June 2023. doi:10.1007/s00134-023-07098-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.